Anticorps anti-LGALS9 humain/souris/rat
Anti-Human/Mouse/Rat LGALS9 Antibody with collaborator-tested evidence for IHC. Read more ›
["IHC"]Product Description
LGALS9 is the stated target for this antibody product. The listing uses collaborator-supplied technical data from Elabscience and is structured for research-use-only antibody selection through ABMIUM.
Product profile: reactivity: Human, Mouse, Rat; host: Rabbit; clonality: Polyclonal; isotype: IgG; available conjugation options: Unconjugated.
Application evidence: Elabscience lists this product for IHC. In the ABMIUM matrix, these listed applications are marked C to show collaborator-tested ABMIUM Verified evidence. Applications not listed in the supplied data remain marked N.
Technical notes: immunogen: Synthetic peptide of human LGALS9; purification: Antigen affinity purification; concentration: 1.08 mg/mL.
Database references: UniProt: O00182 | NCBI Gene: 3965.
Research Use Only.
Key Facts
| Target | LGALS9 |
| Also known as | 36 kDa beta-galactoside-binding lectin, Ecalectin, Gal-9, Galectin-9, HOM HD 21, HOMHD21, HUAT, LEG9, LGAL S9, LGALS 9, LGALS9A, Lectin galactoside binding soluble 9, Lgals9, MGC117375, MGC125973, MGC125974, Tumor antigen HOM-HD-21, UAT, Urate transporter/channel, galectin9 |
| Concentration | 1,08 mg/mL |
| Species reactivity | Humain, Souris, Rat |
| Shelf life | 12 mois à compter des dates d'expédition |
| Research area | Cancer, Biologie cellulaire, Neurosciences |
| WB | IHC-P | IHC-FR | IF/ICC | CYTOMÉTRIE EN FLUX | IP | CHIP | IHC | |
|---|---|---|---|---|---|---|---|---|
| Humain | ||||||||
| Souris | ||||||||
| Rat |
Spécifications
Stockage et stabilité
Conformité et certifications
Manufactured under ISO 9001:2015 quality management standards.
Manufactured under ISO 14001:2015 quality management standards.
Manufactured under ISO 45001:2018 quality management standards.
Not intended for diagnostic or therapeutic use.
Substance does not appear on the SVHC candidate list.